These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20869632)

  • 1. Sex differences in the clinical and serologic presentation of early Lyme disease: Results from a retrospective review.
    Schwarzwalder A; Schneider MF; Lydecker A; Aucott JN
    Gend Med; 2010 Aug; 7(4):320-9. PubMed ID: 20869632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serology in the diagnosis of Lyme disease.
    Brown SL; Hansen SL; Langone JJ
    JAMA; 1999 Jul; 282(1):62-6. PubMed ID: 10404913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.
    Peltomaa M; McHugh G; Steere AC
    Otol Neurotol; 2004 Sep; 25(5):838-41. PubMed ID: 15354020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment.
    Fallon BA; Pavlicova M; Coffino SW; Brenner C
    Clin Infect Dis; 2014 Dec; 59(12):1705-10. PubMed ID: 25182244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre.
    Bernard A; Kodjikian L; Abukhashabh A; Roure-Sobas C; Boibieux A; Denis P; Broussolle C; Seve P
    Br J Ophthalmol; 2018 Mar; 102(3):369-372. PubMed ID: 28659389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological responses in Lyme disease: the influence of sex, age, and environment.
    Fidelus-Gort R; Gilmour RW; Kashatus WC
    Ann Clin Lab Sci; 1993; 23(3):221-9. PubMed ID: 8323257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Western blotting in the serodiagnosis of Lyme disease.
    Dressler F; Whalen JA; Reinhardt BN; Steere AC
    J Infect Dis; 1993 Feb; 167(2):392-400. PubMed ID: 8380611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of OspA vaccination on Lyme disease serologic testing.
    Aguero-Rosenfeld ME; Roberge J; Carbonaro CA; Nowakowski J; Nadelman RB; Wormser GP
    J Clin Microbiol; 1999 Nov; 37(11):3718-21. PubMed ID: 10523583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical manifestation of Lyme borreliosis in children with positive and negatiwe western blot results].
    Ołdak E; Rozkiewicz D; Sulik A
    Przegl Epidemiol; 2008; 62 Suppl 1():77-82. PubMed ID: 22320039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive Lyme serology in optic neuritis.
    Sibony P; Halperin J; Coyle PK; Patel K
    J Neuroophthalmol; 2005 Jun; 25(2):71-82. PubMed ID: 15937426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive serology for Lyme borreliosis in patients with juvenile rheumatoid arthritis in a Lyme borreliosis endemic area: analysis by immunoblot.
    Sood SK; Rubin LG; Blader ME; Ilowite NT
    J Rheumatol; 1993 Apr; 20(4):739-41. PubMed ID: 8496876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyme disease overdiagnosis in a large healthcare system: a population-based, retrospective study.
    Webber BJ; Burganowski RP; Colton L; Escobar JD; Pathak SR; Gambino-Shirley KJ
    Clin Microbiol Infect; 2019 Oct; 25(10):1233-1238. PubMed ID: 30802651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
    Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
    J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four commercially available ELISA assays for the serologic diagnosis of Lyme disease.
    Christenson VD; White DH
    J Clin Lab Anal; 1991; 5(5):340-3. PubMed ID: 1941354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological features of patients with suspected Lyme borreliosis.
    Santino I; Longobardi V
    Int J Immunopathol Pharmacol; 2011; 24(3):797-801. PubMed ID: 21978712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.
    Wilske B; Fingerle V; Herzer P; Hofmann A; Lehnert G; Peters H; Pfister HW; Preac-Mursic V; Soutschek E; Weber K
    Med Microbiol Immunol; 1993 Nov; 182(5):255-70. PubMed ID: 8283961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.